Formulating and Implementing Pharmaceutical Pricing Policies
Challenges, Case Studies and Lessons Learned from Medicine Price Control
- 1st Edition - August 1, 2025
- Imprint: Academic Press
- Editor: Zaheer-Ud-Din Babar
- Language: English
- Paperback ISBN:9 7 8 - 0 - 4 4 3 - 2 3 5 1 8 - 4
- eBook ISBN:9 7 8 - 0 - 4 4 3 - 2 3 5 1 9 - 1
Provides readers with a framework to understand and analyze several medicine pricing policies. Through case studies from countries across geographies and income tiers, this book ex… Read more
Purchase options
Provides readers with a framework to understand and analyze several medicine pricing policies. Through case studies from countries across geographies and income tiers, this book explores the challenges and opportunities related to price control experiences. Studying global policies this book discusses approaches, strategies, and the underlying pharmaceutical pricing practices used to provide advice for formulating highly effective policies. Alongside the cases, this book covers appropriate research methods for pricing analysis, the essential components of pricing policy, data quality, and the generic structure of a pharmaceutical pricing policy.
- Covers the most updated pricing material on the drug pricing control policies
- Demonstrates in real terms, how a medicine pricing policy is formed in a country
- Discusses the empiric basis of forming a medicines pricing policy
Pharmaceutical industry, regulatory and access, healthcare professionals, governments, policy makers, pharmacists, physicians, academic researchers, Health policy, global health, economics, finance, public policy, trade and investment professionals
1. Pharmaceutical pricing policies: Introduction, key concepts and evidence synthesis
2. Analysis of anti-retroviral medicines prices: A review of literature
3. Evidence on pharmaceutical pricing policies in Europe
4. Pharmaceutical pricing policies in Italy
5. Pharmaceutical pricing policies in Indonesia
6. Canada’s medicine pricing policies: implementation strategies and models
7. Pharmaceutical pricing policies in Thailand
8. Pharmaceutical Pricing Policies in China: An Evidence Synthesis Analysis
9. Strategies for medicine pricing in Southeast Asia
10. Pharmaceutical pricing policies in Syria
11. Pharmaceutical pricing policies in Finland- An example of uptake of less expensive biologic medicines
12. Integrating Citizens’ Voices in Pharmaceutical Pricing and Reimbursement
13. Pharmaceutical pricing policies in Spain
14. Pharmaceutical pricing strategies in the US
15. Money matters – How financing for medicines R&D affects medicines, and what to do about it
16. The role of Civil Society Organizations ensuring price transparency
17. How to Price Advanced Therapies? Mixed approach for valuing a new CAR-T Cell for Multiple Myeloma in Brazil
18. Pharmaceutical pricing policies in Greece
2. Analysis of anti-retroviral medicines prices: A review of literature
3. Evidence on pharmaceutical pricing policies in Europe
4. Pharmaceutical pricing policies in Italy
5. Pharmaceutical pricing policies in Indonesia
6. Canada’s medicine pricing policies: implementation strategies and models
7. Pharmaceutical pricing policies in Thailand
8. Pharmaceutical Pricing Policies in China: An Evidence Synthesis Analysis
9. Strategies for medicine pricing in Southeast Asia
10. Pharmaceutical pricing policies in Syria
11. Pharmaceutical pricing policies in Finland- An example of uptake of less expensive biologic medicines
12. Integrating Citizens’ Voices in Pharmaceutical Pricing and Reimbursement
13. Pharmaceutical pricing policies in Spain
14. Pharmaceutical pricing strategies in the US
15. Money matters – How financing for medicines R&D affects medicines, and what to do about it
16. The role of Civil Society Organizations ensuring price transparency
17. How to Price Advanced Therapies? Mixed approach for valuing a new CAR-T Cell for Multiple Myeloma in Brazil
18. Pharmaceutical pricing policies in Greece
- Edition: 1
- Published: August 1, 2025
- Imprint: Academic Press
- Language: English
ZB
Zaheer-Ud-Din Babar
Professor Zaheer Babar is a Professor of Clinical Pharmacy and Practice at the College of
Pharmacy, Qatar University, and serves as a Visiting Professor in the Department of Pharmacy
at the University of Huddersfield in the United Kingdom. He has extensively published research
on medicine pricing and access to medications, gaining international recognition for his
contributions to pharmaceutical policy. Professor Babar has collaborated with organizations
such as the United Nations Development Programme (UNDP), Health Action International,
Management Sciences for Health (MSH), the International Union Against Tuberculosis and
Lung Disease, and the World Bank to develop medicine pricing policies for various countries.
His edited work include “Economic Evaluation of Pharmacy Services,” “Pharmaceutical Prices
in the 21st Century,” “Pharmaceutical Policies in Countries with Developing Healthcare
Systems,” “Global Pharmaceutical Policy,” “Access to High-Cost Medicines,” “Pharmacy
Practice Research Methods,” “Pharmacy Practice Research Case Studies,” “Encyclopedia of
Pharmacy Practice and Clinical Pharmacy.” And “Encyclopedia of Evidence in Pharmaceutical
Public Health and Health Services Research in Pharmacy.”
Affiliations and expertise
Professor in Medicines and Healthcare, Director, Centre for Pharmaceutical Policy and Practice Research, Department of Pharmacy, University of Huddersfield, UK